Vitamin B12 and Folate — Deficiency

Key Mechanism 1: Impaired DNA Synthesis and the Methyl-Trap Hypothesis

Key Mechanism 2: Differential Effects on Cell Types Based on Replication Rate

Key Mechanism 3: Neurologic Damage via Impaired Myelin Synthesis

Key Mechanism 4: Homocysteine Elevation and Vascular Complications

Key Mechanism 5: Vitamin B12 Absorption and Parietal Cell Loss

B12 Deficiency Etiologies

• Pernicious Anemia (Autoimmune Gastritis): The most common cause in developed countries. Autoantibodies against parietal cells and/or intrinsic factor progressively destroy gastric mucosa, eliminating IF production and reducing gastric acid. Associations include northern European descent, family history, autoimmune thyroid disease, and premature gray hair. Atrophic gastritis develops insidiously over years.

• Gastrointestinal Malabsorption and Surgical Causes: Gastrectomy (partial or total) removes the site of IF synthesis; ileal resection or Crohn's disease removes the anatomic site of B12 absorption. Small bowel bacterial overgrowth (SIBO) and tropical sprue consume B12. Pancreatic insufficiency impairs the digestion of R-factor-bound B12. Fish tapeworm (Diphyllobothrium latum) infection, endemic in Scandinavia and Eastern Europe, competes with the host for B12 absorption.

• Dietary Insufficiency: Rare in omnivores but common in strict vegans (no animal products). B12 is present only in animal products and fortified foods; plant sources do not contain bioavailable B12. Vegans require supplementation or fortified foods. Elderly patients with poor intake and those with severe malnutrition are also at risk.

• Pernicious Medications: Metformin reduces B12 absorption (10–30% of chronic users); proton pump inhibitors and H2-receptor antagonists reduce gastric acid, impairing food-cobalamin malabsorption, particularly relevant in elderly patients. Colchicine and neomycin impair B12 absorption.

• Metabolic Diseases: Inborn errors of B12 metabolism (cobalamin C, D, E defects) are rare but cause neurologic disease in infancy or childhood.

Folate Deficiency Etiologies

• Nutritional Deficiency: The most common cause globally. Vegetables, legumes, and fortified grains are primary sources. Folate is heat-labile; overcooking destroys it. Poor intake occurs in malnutrition, alcoholism (alcohol impairs absorption and metabolism), and elderly patients with restricted diets. In the United States, folate deficiency is uncommon due to grain fortification mandated since 1998.

• Gastrointestinal Malabsorption: Celiac disease, tropical sprue, Crohn's disease, and short bowel syndrome impair folate absorption in the proximal small bowel. Medications including sulfasalazine and methotrexate impair folate metabolism.

• Increased Utilization: Pregnancy and lactation substantially increase folate requirements (up to 800 mcg daily), making deficiency common if not supplemented. Rapidly dividing tumors (leukemia, lymphoma) consume folate. Hemolytic anemias require increased erythropoiesis and folate consumption.

• Medications: Methotrexate (used in cancer and autoimmune disease) is a dihydrofolate reductase inhibitor, blocking folate metabolism. Phenytoin, sulfasalazine, and trimethoprim impair folate metabolism or absorption.

Hematologic Manifestations (Common to Both Deficiencies)

• Macrocytic Anemia with Symptoms of Anemia: Pallor, fatigue, dyspnea on exertion, palpitations, and reduced exercise tolerance result from decreased oxygen-carrying capacity. Severity correlates with hemoglobin level and acuity of onset. Symptoms typically appear when hemoglobin falls below 7–8 g/dL, though individual tolerance varies.

• Glossitis and Angular Cheilitis: Inflammation of the tongue and cracks at the corners of the mouth occur due to impaired DNA synthesis in rapidly dividing oral epithelium. Patients report a sore, "beefy red" tongue and difficulty eating spicy or hot foods.

• Diarrhea and Abdominal Discomfort: Impaired DNA synthesis affects rapidly dividing intestinal epithelial cells, causing villous atrophy, malabsorption, and diarrhea (often watery and chronic). Associated with abdominal discomfort and potential secondary malabsorption.

• Hypersegmented Neutrophils on Blood Smear: A pathognomonic finding of megaloblastic anemia; neutrophils with >5 nuclear lobes (vs. normal 3–4 lobes) represent impaired nuclear maturation. Not present in all cases but highly specific when found.

B12 Deficiency-Specific Neurologic Manifestations (Subacute Combined Degeneration)

• Paresthesias and Neuropathy (Distal Symmetric): Demyelination of peripheral nerves causes "stocking-glove" paresthesias (tingling and numbness) beginning distally in the feet and progressing proximally. Patients report numbness, burning, or "pins and needles" sensation. This is often the earliest neurologic symptom.

• Dorsal Column Dysfunction—Impaired Proprioception and Vibration: Loss of position sense (proprioception) and vibration perception in the legs causes sensory ataxia. Patients describe difficulty walking, particularly in the dark or with eyes closed (positive Romberg sign). Loss of vibration sense begins distally in the toes and progresses proximally.

• Lateral Corticospinal Tract Involvement—Upper Motor Neuron Signs: Hyperreflexia, spasticity, and eventually weakness of the legs (especially hip and knee extensors) reflect pyramidal tract involvement. The combination of hyporeflexia (from peripheral neuropathy) with hyperreflexia (from corticospinal involvement) can occur, creating an unusual mixed pattern.

• Cognitive and Psychiatric Manifestations: "Megaloblastic madness" includes memory loss, poor concentration, irritability, depression, and rarely psychosis or dementia. Mechanisms include impaired methylation in the brain and direct neuronal dysfunction from accumulated metabolites. Cognitive changes may precede hematologic manifestations.

• Optic Neuropathy and Impotence: Rare but documented neurologic complications reflecting demyelination in the optic nerves and autonomic dysfunction, respectively.

• Critical Point—Reversibility Timeline: Neurologic symptoms begin reversing within days to weeks of B12 repletion if caught early (weeks of deficiency), but become irreversible after months of untreated deficiency due to axonal degeneration and neuronal loss. This underscores the importance of early diagnosis.

Folate Deficiency-Specific Features

• Absence of Neurologic Manifestations: Folate deficiency does NOT cause neurologic disease, a critical distinguishing feature. Patients with isolated folate deficiency present with anemia and mucosal symptoms only.

Physical Examination Findings

• Pallor of conjunctivae and nail beds (reflecting anemia)
• Glossitis with erythematous, beefy red, smooth tongue
• Splenomegaly (moderate) due to extramedullary hematopoiesis
• Hepatomegaly (mild) from extramedullary hematopoiesis
• Neurologic exam in B12 deficiency: decreased vibration and proprioception, positive Romberg sign, hyperreflexia, positive Babinski sign (if corticospinal involvement), ataxic gait

Clinical Variants and Important Presentations

• Neurologically Asymptomatic B12 Deficiency: Some patients present with purely hematologic disease and no neurologic symptoms at the time of diagnosis, yet may develop them if B12 is not repleted. Screening for subclinical neurologic disease (vibration sense, proprioception) is important.

• "Normal" Hemoglobin with Neurologic B12 Deficiency: In rare cases, particularly early in disease or in patients with concurrent iron deficiency (which lowers MCV), patients may present with neurologic disease despite a normal or low-normal hemoglobin and non-macrocytic indices. A high index of suspicion is needed.

• Combined Deficiencies: Patients with celiac disease, alcoholism, or malnutrition may have both B12 and folate deficiency simultaneously, presenting with severe megaloblastic anemia and potential neurologic disease.

Laboratory Tests and Interpretation

• Complete Blood Count (CBC) and Reticulocyte Count: Macrocytic anemia (MCV >100 fL) with hypochromic, microcytic cells absent. Hemoglobin and hematocrit are reduced proportional to deficiency severity. Platelets and WBC may be reduced (pancytopenia in severe cases). Reticulocyte count is inappropriately low or normal (should be elevated in response to anemia), reflecting impaired erythropoiesis due to defective DNA synthesis. This inappropriately low reticulocyte count is a key finding distinguishing megaloblastic from hemolytic anemias.

• Peripheral Blood Smear: Hypersegmented neutrophils (>5 lobes, 100% specificity but only 50–60% sensitivity) are pathognomonic when present. Giant platelets may be seen. Nucleated RBCs and immature WBC may appear if severe marrow involvement. Anisocytosis and poikilocytosis reflect variable cell sizes.

• Serum B12 Level: Normal >200–300 pg/mL (varies by lab). Deficiency is typically defined as <200 pg/mL (150 pg/mL in some labs). Low B12 with clinical or laboratory evidence of deficiency is diagnostic. However, "low-normal" B12 levels (200–300 pg/mL) may be associated with early deficiency or subclinical disease; in this range, further testing

Immediate stabilisation

• Transfusion is rarely first-line: megaloblastic anemia is chronic and plasma volume is expanded, so transfusion risks volume overload and pulmonary edema. Reserve for hemodynamic compromise, angina, or high-output failure, and give slowly (one unit at a time, with a loop diuretic such as furosemide).
• Empiric B12 before folate: if both deficiencies are possible and treatment cannot wait for results, draw B12, folate, methylmalonic acid, and homocysteine, then treat with cobalamin first. Folate monotherapy in an unrecognized B12 deficiency corrects the anemia while permitting subacute combined degeneration to progress — the classic contraindication emphasized by the British Society for Haematology cobalamin/folate guidance.

First-line therapy — B12 deficiency

• Parenteral cobalamin (cyanocobalamin or hydroxocobalamin): 1000 mcg IM, given daily to every other day for about a week, then weekly, then monthly for life in pernicious anemia or ileal disease. Neurologic involvement warrants the more intensive loading schedule.
• High-dose oral cobalamin (1000–2000 mcg daily): acceptable for non-neurologic, absorption-intact deficiency (dietary, metformin- or PPI-associated), and adequate even in pernicious anemia because roughly 1% of an oral dose is absorbed by passive diffusion independent of intrinsic factor. Adherence must be reliable.

First-line therapy — folate deficiency

• Oral folic acid (1–5 mg daily) until stores are replete and the cause is corrected; lifelong in chronic hemolysis or ongoing malabsorption.
• Preventive dosing: the USPSTF recommends 0.4–0.8 mg daily for all persons planning or capable of pregnancy; ACOG recommends 4 mg daily preconception for a prior neural-tube-defect pregnancy.

Treat the cause / escalation

• Antibiotics for small-bowel bacterial overgrowth, praziquantel for Diphyllobothrium latum, gluten-free diet for celiac disease, pancreatic enzyme replacement, leucovorin (folinic acid) rather than folic acid for methotrexate toxicity.
• Stop the offending exposure: nitrous oxide (irreversibly oxidizes cobalamin), and review metformin and acid suppression.

Complications of the disease

• Irreversible subacute combined degeneration: prolonged demyelination of dorsal columns and corticospinal tracts progresses to axonal loss. Signalled by persistent sensory ataxia, positive Romberg, spasticity, and bladder dysfunction that fail to improve after months of repletion. Early treatment is the only protection.
• High-output heart failure and anemic hypoxia: severe anemia with compensatory tachycardia and increased stroke volume; dyspnea at rest, S3, and pulmonary edema. This is an emergency requiring cautious transfusion.
• Pseudo-thrombotic microangiopathy: ineffective erythropoiesis with intramedullary hemolysis produces markedly elevated LDH, low haptoglobin, indirect hyperbilirubinemia, schistocytes, and thrombocytopenia — a near-perfect TTP mimic. The distinguishing features are macrocytosis, hypersegmented neutrophils, and a low reticulocyte count. Misclassification leads to unnecessary plasma exchange.
• Pancytopenia: marrow-wide nuclear maturation arrest; neutropenic infection and bleeding are the danger signals.
• Hyperhomocysteinemia: endothelial injury and prothrombotic state, with increased venous thromboembolism and atherothrombotic risk.
• Pregnancy-related complications of folate deficiency: neural tube defects (anencephaly, spina bifida), signalled by elevated maternal serum AFP or ultrasound findings.
• Gastric adenocarcinoma and type 1 gastric carcinoid in pernicious anemia: chronic atrophic gastritis with hypergastrinemia and ECL-cell hyperplasia. New dyspepsia, iron deficiency, or weight loss should prompt endoscopy.
• Neuropsychiatric decline (megaloblastic madness): dementia-like cognitive impairment; B12 is part of the reversible-dementia workup.

Complications of treatment

• Hypokalemia: the burst of erythropoiesis after repletion drives potassium intracellularly. Weakness, ileus, U waves, and arrhythmia within the first days — an emergency; monitor and replete potassium.
• Folate given alone in B12 deficiency: hematologic response masks progressive myelopathy — the single most tested iatrogenic error.
• Unmasked iron deficiency and rebound thrombocytosis: falling MCV with continued anemia; check ferritin.
• Hyperuricemia/gout from high cell turnover; rare hypersensitivity to injected cobalamin.

• Methylmalonic acid is the discriminator: MMA and homocysteine both rise in B12 deficiency; only homocysteine rises in folate deficiency. When serum B12 is borderline (roughly 200–300 pg/mL), the single best next step is to measure MMA (with or without homocysteine) rather than to start empiric therapy blindly.
• Never give folate alone when B12 status is unknown: the anemia corrects, the myelopathy marches on. This is the most common distractor answer on treatment stems.
• Hypersegmented neutrophils (>5 lobes) plus an inappropriately low reticulocyte count is the smear signature; combined with a beefy red tongue, it is a giveaway for megaloblastic anemia.
• Store size drives the timeline: hepatic B12 stores last years, so dietary B12 deficiency takes 3–5 years to appear; folate stores last only weeks to months, so alcoholism, pregnancy, or hemolysis can precipitate deficiency quickly.
• The association examiners love is pernicious anemia: anti-intrinsic-factor antibody is highly specific (anti-parietal-cell antibody is sensitive but not specific), and it clusters with autoimmune thyroid disease, vitiligo, and type 1 diabetes. The Schilling test is obsolete — do not pick it.
• Nitrous oxide (dental or recreational whippet use) irreversibly oxidizes cobalamin: a young patient with sensory ataxia, a positive Romberg, and a normal-appearing CBC. MRI shows dorsal column T2 hyperintensity — the inverted V sign.
• Normal MCV does not exclude B12 deficiency: coexisting iron deficiency or thalassemia trait can normalize the MCV while neurologic disease progresses.
• After starting therapy, check potassium and expect reticulocytosis in 3–7 days; a falling MCV with persistent anemia means unmasked iron deficiency, not treatment failure.
• Metformin and chronic PPI use are the two drug stems that most often hide a low B12.